Literature DB >> 6168688

Helper cells active in the generation of cytotoxicity to a syngeneic tumor.

E J Hancock, D G Kilburn, J G Levy.   

Abstract

We have examined a population of thymic lymphocytes that augment the generation in vitro of specific cytotoxic T cells against P815.X2, a syngeneic tumor in DBA/2 mice. These helper cells are evident in the thymus of DBA/2 mice 5 to 7 days after subcutaneous injection of live P815 cells. They are Thy-1 positive, resistant to gamma radiation, antigen specific, and appear to exert their influence most effectively when added at the beginning of the culture.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6168688

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipients.

Authors:  W Den Otter; J W De Groot; H F Dullens
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

2.  Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy.

Authors:  M M Bartik; M C Ahn; B A Baumgartel; R L Hendricks; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Interleukin 2 activity in peripheral blood mononuclear cells of patients with gynecologic malignancies.

Authors:  Y Kikuchi; T Kita; K Oomori; M Miyauchi; I Iwano; I Kizawa
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

4.  The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour.

Authors:  E J Hancock; D G Kilburn
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

5.  Effects of PSK on interleukin-2 production by peripheral lymphocytes of patients with advanced ovarian carcinoma during chemotherapy.

Authors:  Y Kikuchi; I Kizawa; K Oomori; I Iwano; T Kita; K Kato
Journal:  Jpn J Cancer Res       Date:  1988-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.